The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.5K Targets. Of those, 1.4M data for 679K Compounds and 4.6K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

16 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)-acetamides and carboxamides.EBI
University Health Network
Interrogation of the Active Sites of Protein Arginine Deiminases (PAD1, -2, and -4) Using Designer Probes.EBI
University Health Network
Novel inhibitors of protein arginine deiminase with potential activity in multiple sclerosis animal model.EBI
University Health Network
Novel cytidine-based orotidine-5'-monophosphate decarboxylase inhibitors with an unusual twist.EBI
University Health Network
Novel interactions of fluorinated nucleotide derivatives targeting orotidine 5'-monophosphate decarboxylase.EBI
University Health Network
Structural determinants for the inhibitory ligands of orotidine-5'-monophosphate decarboxylase.EBI
University Health Network
Design, synthesis, and biological evaluation of furosemide analogs as therapeutics for the proteopathy and immunopathy of Alzheimer's disease.EBI
University Health Network
Mechanisms of Specific versus Nonspecific Interactions of Aggregation-Prone Inhibitors and Attenuators.EBI
University Health Network
Identification of Potent Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors Based on a Phenylimidazole Scaffold.EBI
University Health Network
Inhibitors of protein arginine deiminases and their efficacy in animal models of multiple sclerosis.EBI
University Health Network
5-membered heteroaryl carboxamide compounds for treatment of HBVBDB
Assembly Biosciences
Difluoroketamide derivatives as HtrA1 inhibitorsBDB
Hoffmann-La Roche
Oxadiazole transient receptor potential channel inhibitorsBDB
Genentech
Pyrrolo[1,2-b]pyridazine derivativesBDB
Gilead Sciences
Matriptase inhibitors and uses thereof against orthomyxoviridae infectionsBDB
TBA
Substituted pyridizinone derivatives as PDE10 inhibitorsBDB
Merck Sharp & Dohme